New Delhi: In the wake of the COVID-19 pandemic, the Government of India is striving to ensure sufficient availability of critical medical equipment for clinical management of COVID-19 in the country. Ministry of Health & Family Welfare (MoH&FW) has identified a list of critical medical equipment for the same and has requested National Pharmaceutical Pricing Authority (NPPA) to ensure availability of the same in the country, a PIB release stated.
The Government is committed to the availability of life-saving drugs/devices at affordable prices to the consumers. All the medical devices have been notified as Drugs and have come under regulatory regime of the Drugs & Cosmetics Act, 1940 and Drugs (Prices (Control Order), 2013 w.e.f. 1st April 2020. In order to keep a check on the price rise of critical medical equipment, NPPA, in the exercise of powers conferred under DPCO, 2013, has called for price related data from manufacturers/importers of (i) Pulse Oximeter and (ii) Oxygen Concentrator to ensure that prices existing as on 1st April 2020 should not be increased more than 10% in a year, the release said.
A Stakeholders Consultation with Medical Devices Industry Associations and Civil Society Group was held in NPPA on 1st July 2020 wherein it was stressed that all the manufacturers/importers of critical medical equipment shall ensure sufficient availability of the same in the country. It has been reiterated that all the Medical Devices have come under price regulation under DPCO, and accordingly, price increase of medical devices would be monitored under Para 20, the PIB release added.
Also Read: Kamrup (M) Admin fixes retail price for Potatoes and Onions...